POC血糖検査の世界市場レポート 2024

POC血糖検査の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.3%の年間複合成長率（CAGR）で59億9,000万米ドルに成長すると予想されます。予測期間の成長は、遠隔医療サービスの拡大、糖尿病ケアにおける個別化医療の重視の高まり、糖尿病管理プログラムの普及、グルコース検査に関連する研究開発への投資の増加、および継続的検査の導入によるものと考えられます。予測期間中の主な動向には、ウェアラブル血糖モニタリングデバイスの開発、血糖検査におけるスマートフォン接続の統合、在宅ヘルスケア環境におけるポイントオブケア検査の普及、血糖データ分析における人工知能の導入、および糖尿病患者の遠隔モニタリングの拡大などが予測されます。

POC血糖検査市場は、糖尿病の有病率の増加により成長すると予想されています。血糖値を上昇させる慢性代謝疾患である糖尿病は、時間の経過とともにさまざまな臓器に重大なリスクをもたらします。 POC血糖検査は広く使用されているテクノロジーで、入院患者の血糖値の測定に役立ち、血糖の変化に応じた迅速な治療法の決定を容易にします。特に、この技術は治療成果を高め、糖尿病管理を改善します。米国疾病管理予防センター（CDC）による2022年の統計によると、2021年には米国で約3,730万人が糖尿病を患っており、人口の11.3％を占めました。さらに、国際糖尿病連盟が2021年 11月に発表した予測では、世界の糖尿病人口は2030年の6億4,300万人（11.3%）から2045年までに7億8,300万人（12.2%）に増加すると予測されており、POC血糖検査市場に対する糖尿病の重大な影響が浮き彫りになっています。

POC血糖検査市場の成長は、高齢化人口の増加によってさらに加速されています。人口動態が高齢化に移行し、高齢者の割合が増加するのに伴い、POC血糖検査の重要性がますます高まっています。この技術は、高齢者、特に糖尿病のリスクが高い人やすでに糖尿病と診断されている人にとって重要な目的を果たします。世界保健機関は、2030年までに世界の6人に1人が60歳以上になると予測しています。 60歳以上の人口に占める割合は2020年の10億人から14億人に増加すると予想されており、2050年までに世界の60歳以上の人口は2倍の21億人に達すると予想されています。したがって、高齢化人口の増加はPOC血糖検査市場の重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のPOC血糖検査市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ランセットおよびランシング装置
• ストリップ
• メーター
• 世界のPOC血糖検査市場、検査部位別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 指先
• 代替部位検査
• 世界のPOC血糖検査市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 1型糖尿病
• 2型糖尿病
• 世界のPOC血糖検査市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 専門の診断センター
• 病院と診療所
• 在宅ケア環境
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のPOC血糖検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のPOC血糖検査市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• POC血糖検査市場の競合情勢
• POC血糖検査市場の企業プロファイル
  • F Hoffmann-La Roche Ltd.
  • Abbott Laboratories Inc.
  • Danaher Corporation
  • Siemens Healthineers
  • Becton, Dickinson and Company

第31章 その他の大手および革新的な企業

• TaiDoc Technology Corporation
• B. Braun Melsungen AG
• Beckman Coulter Inc.
• Nipro Corporation
• Dexcom Inc.
• Bio-Rad Laboratories Inc.
• LifeScan Inc.
• Nova Biomedical Corporation
• Ypsomed AG
• Ascensia Diabetes Care Holdings AG
• Trividia Health Inc.
• Radiometer Medical ApS
• HemoCue AB
• EKF Diagnostics Holdings plc
• Trinity Biotech plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Point-of-care glucose testing denotes a quality-assured pathology service administered in close proximity to the patient rather than within the conventional confines of a clinical laboratory. Clinicians or individuals employ small handheld units or glucose analyzers, along with testing strips, for glucose testing on whole blood. This approach reduces the duration from specimen collection to result verification, leading to swifter therapeutic intervention, diminished preanalytical errors, and enhanced patient care.

The primary components in point-of-care glucose testing encompass lancet and lancing devices, strips, and meters. Lancets, small sharp instruments, puncture the skin to extract a small blood drop for testing, while lancing devices securely hold the lancet and are activated with a simple button push. These devices facilitate straightforward blood withdrawal and assessment of blood glucose levels using a blood glucose monitor and test strips in point-of-care glucose testing. Testing sites include fingertips and alternate site testing, applied in both type-1 and type-2 diabetes. Various end-users, such as professional diagnostic centers, hospitals and clinics, home care settings, among others, utilize these methods.

The point-of-care glucose testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care glucose testing market statistics, including point-of-care glucose testing industry global market size, regional shares, competitors with a point-of-care glucose testing market share, detailed point-of-care glucose testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care glucose testing industry. This point-of-care glucose testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care glucose testing market size has grown strongly in recent years. It will grow from $4.63 billion in 2023 to $4.88 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The growth observed in the historical period can be credited to the increasing prevalence of diabetes, heightened awareness of diabetes management, the expansion of the aging population, the augmentation of healthcare infrastructure, and the adoption of point-of-care testing.

The point-of-care glucose testing market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be ascribed to the expansion of telemedicine services, an increasing emphasis on personalized medicine in diabetes care, the proliferation of diabetes management programs, heightened investment in research and development related to glucose testing, and the adoption of continuous glucose monitoring. Key trends expected in the forecast period encompass the development of wearable glucose monitoring devices, the integration of smartphone connectivity in glucose testing, the proliferation of point-of-care testing in home healthcare settings, the adoption of artificial intelligence in glucose data analysis, and the expansion of remote patient monitoring for diabetes.

The point-of-care glucose testing market is anticipated to experience growth, driven by the increasing prevalence of diabetes. Diabetes, a chronic metabolic disorder elevating blood glucose levels, poses severe risks to various organs over time. Point-of-care glucose testing, a widely used technology, aids in determining glucose levels in hospitalized patients, facilitating prompt treatment decisions in response to glycemic changes. Notably, this technology enhances therapeutic outcomes and improves diabetes management. Statistics from 2022 by the Centers for Disease Control and Prevention (CDC) revealed that around 37.3 million people had diabetes in the United States in 2021, constituting 11.3% of the population. Additionally, projections from the International Diabetes Federation in November 2021 forecasted a global diabetic population increase from 643 million (11.3%) in 2030 to 783 million (12.2%) by 2045, underscoring the significant impact of diabetes on the point-of-care glucose testing market.

The growth of the point-of-care glucose testing market is further fueled by the rising aging population. As demographics shift toward an aging population, characterized by an increasing proportion of elderly individuals, point-of-care glucose testing becomes increasingly crucial. This technology serves essential purposes for older individuals, particularly those at higher risk of diabetes or already diagnosed. The World Health Organization projected that by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion, and by 2050, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion. Therefore, the growing aging population is a significant driver of the point-of-care glucose testing market.

Product innovation is a key trend gaining traction in the point-of-care glucose testing market, with major companies focused on developing innovative products. For instance, F. Hoffmann-La Roche AG introduced Cobas Pulse in January 2022, a new point-of-care blood glucose monitor designed for healthcare staff. This handheld device includes an automated glucose test strip reader, camera, and touchscreen, housed in a rugged casing that can be disinfected and used across all age groups, including newborns and intensive care patients. The innovation aims to enhance physicians' workflow by integrating Glucommander dosage software and offering downloadable decision-support apps.

Major companies in the point-of-care glucose testing market are also directing their efforts towards developing advanced solutions such as glucose-ketone monitoring sensors. Abbott Laboratories announced in June 2022 the development of a first-of-its-kind biowearable sensor system that continuously monitors glucose and ketones in diabetic patients. This breakthrough device, granted FDA designation, represents a significant advancement in regulatory status and is set to become the most compact and slender monitoring device globally. It integrates seamlessly with Abbott's digital ecosystem, allowing remote monitoring by healthcare professionals.

In November 2021, Johnson & Johnson acquired Inverness Medical Technology for $1.3 billion, aiming to strengthen its product portfolio in glucose testing. Inverness Medical Technology, a medical device company, brought valuable resources and a robust pipeline of blood glucose meters and test strips to enhance Johnson & Johnson's competitive position in the point-of-care glucose testing market.

Major companies operating in the point-of-care glucose testing market report are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings PLC, Trinity Biotech PLC, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Bluedrop Medical Limited

North America was the largest region in the point of care glucose testing market in 2023. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care glucose testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care glucose testing market consists of revenues earned by entities by providing services such as diagnosis, monitoring, screening, and testing regimes to offer enhanced therapeutic intervention and patient care in lesser time. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care glucose testing market also includes sales of rapid assay dipsticks, glucose monitoring kits, and multifunctional benchtop devices which are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care Glucose Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care glucose testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care glucose testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care glucose testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Lancet And Lancing Devices; Strips; Meters
• 2) By Testing Site: Fingertips; Alternate Site Testing
• 3) By Applications: Type-1 Diabetes; Type-2 Diabetes
• 4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users
• Companies Mentioned: F Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Danaher Corporation; Siemens Healthineers; Becton, Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care Glucose Testing Market Characteristics

3. Point-of-Care Glucose Testing Market Trends And Strategies

4. Point-of-Care Glucose Testing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Point-of-Care Glucose Testing Market Size and Growth

• 5.1. Global Point-of-Care Glucose Testing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Point-of-Care Glucose Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Point-of-Care Glucose Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Point-of-Care Glucose Testing Market Segmentation

• 6.1. Global Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Lancet And Lancing Devices
• Strips
• Meters
• 6.2. Global Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Fingertips
• Alternate Site Testing
• 6.3. Global Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Type-1 Diabetes
• Type-2 Diabetes
• 6.4. Global Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Professional Diagnostic Centers
• Hospitals And Clinics
• Home Care Settings
• Other End Users

7. Point-of-Care Glucose Testing Market Regional And Country Analysis

• 7.1. Global Point-of-Care Glucose Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Point-of-Care Glucose Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Point-of-Care Glucose Testing Market

• 8.1. Asia-Pacific Point-of-Care Glucose Testing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Point-of-Care Glucose Testing Market

• 9.1. China Point-of-Care Glucose Testing Market Overview
• 9.2. China Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Point-of-Care Glucose Testing Market

• 10.1. India Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Point-of-Care Glucose Testing Market

• 11.1. Japan Point-of-Care Glucose Testing Market Overview
• 11.2. Japan Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Point-of-Care Glucose Testing Market

• 12.1. Australia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Point-of-Care Glucose Testing Market

• 13.1. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Point-of-Care Glucose Testing Market

• 14.1. South Korea Point-of-Care Glucose Testing Market Overview
• 14.2. South Korea Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Point-of-Care Glucose Testing Market

• 15.1. Western Europe Point-of-Care Glucose Testing Market Overview
• 15.2. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Point-of-Care Glucose Testing Market

• 16.1. UK Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Point-of-Care Glucose Testing Market

• 17.1. Germany Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Point-of-Care Glucose Testing Market

• 18.1. France Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Point-of-Care Glucose Testing Market

• 19.1. Italy Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Point-of-Care Glucose Testing Market

• 20.1. Spain Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Point-of-Care Glucose Testing Market

• 21.1. Eastern Europe Point-of-Care Glucose Testing Market Overview
• 21.2. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Point-of-Care Glucose Testing Market

• 22.1. Russia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Point-of-Care Glucose Testing Market

• 23.1. North America Point-of-Care Glucose Testing Market Overview
• 23.2. North America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Point-of-Care Glucose Testing Market

• 24.1. USA Point-of-Care Glucose Testing Market Overview
• 24.2. USA Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Point-of-Care Glucose Testing Market

• 25.1. Canada Point-of-Care Glucose Testing Market Overview
• 25.2. Canada Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Point-of-Care Glucose Testing Market

• 26.1. South America Point-of-Care Glucose Testing Market Overview
• 26.2. South America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Point-of-Care Glucose Testing Market

• 27.1. Brazil Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Point-of-Care Glucose Testing Market

• 28.1. Middle East Point-of-Care Glucose Testing Market Overview
• 28.2. Middle East Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Point-of-Care Glucose Testing Market

• 29.1. Africa Point-of-Care Glucose Testing Market Overview
• 29.2. Africa Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Point-of-Care Glucose Testing Market Competitive Landscape And Company Profiles

• 30.1. Point-of-Care Glucose Testing Market Competitive Landscape
• 30.2. Point-of-Care Glucose Testing Market Company Profiles
  • 30.2.1. F Hoffmann-La Roche Ltd.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Abbott Laboratories Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Danaher Corporation
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Siemens Healthineers
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Becton, Dickinson and Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Point-of-Care Glucose Testing Market Other Major And Innovative Companies

• 31.1. TaiDoc Technology Corporation
• 31.2. B. Braun Melsungen AG
• 31.3. Beckman Coulter Inc.
• 31.4. Nipro Corporation
• 31.5. Dexcom Inc.
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. LifeScan Inc.
• 31.8. Nova Biomedical Corporation
• 31.9. Ypsomed AG
• 31.10. Ascensia Diabetes Care Holdings AG
• 31.11. Trividia Health Inc.
• 31.12. Radiometer Medical ApS
• 31.13. HemoCue AB
• 31.14. EKF Diagnostics Holdings plc
• 31.15. Trinity Biotech plc

32. Global Point-of-Care Glucose Testing Market Competitive Benchmarking

33. Global Point-of-Care Glucose Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Point-of-Care Glucose Testing Market

35. Point-of-Care Glucose Testing Market Future Outlook and Potential Analysis

• 35.1 Point-of-Care Glucose Testing Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Point-of-Care Glucose Testing Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Point-of-Care Glucose Testing Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer